Drayson's Sensyne Health trades up 8.6% after IPO on AIM
Sensyne Health, the UK healthcare artificial intelligence company, has traded up nicely after the company priced its IPO on London’s alternative investment market (AIM).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: